Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Clinical Response Correlate With Serum Certolizumab Levels? A Prospective Open Label Trial of Adult Patients With Active Crohn's Disease (APOLLO)

NCT02597829 is registered in ClinicalTrials.gov with Shafran Gastroenterology Center as lead sponsor.

NCT NCT02597829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02597829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Clinical Response Correlate With Serum Certolizumab Levels? A Prospective Open Label Trial of Adult Patients With Active Crohn's Disease (APOLLO)
Lead sponsor
Shafran Gastroenterology Center
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2015
Completion date
October 31, 2018
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease